Skip to content

ABUS

Arbutus Biopharma Corp

NASDAQ · Healthcare · Biotechnology · US

$5.01
−1.18%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
6.76x
P/E 2027E
P/E 2028E
P/S forward
248.13x

Trailing multiples

Trailing twelve months

P/E TTM
6.34x
PEG TTM
Price / book
3.84x
Price / sales
5.46x
Price / cash flow
-40.30x

Enterprise value

Enterprise value
$903.5M
EV / sales
4.97x
EV / EBITDA
5.90x
EV / EBIT
6.14x
Market cap
$992.5M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026